Abstract: Homoclinic and heteroclinic solutions to a standard hepatitis C virus (HCV) evolution model described by T. C. Reluga, H. A. S. Perelson, (SIAM J. Appl. Math., 69 (2009), pp. 999-1023) are considered in this paper. Inverse balancing and generalized di erential techniques enable derivation of necessary and su cient existence conditions for homoclinic/heteroclinic solutions in the considered system. It is shown that homoclinic/heteroclinic solutions do appear when the considered system describes biologically signi cant evolution. Furthermore, it is demonstrated that the hepatitis C virus evolution model is structurally stable in the topological sense and does maintain homoclinic/heteroclinic solutions as di usive coupling coe cients tend to zero. Computational experiments are used to illustrate the dynamics of such solutions in the hepatitis C evolution model.
Introduction
Modeling of biomedical processes using di erential equations has become more and more widespread over recent years [6, 12, 29] . Various di erential equation models on the use of oncolytic viruses as therapeutic agents against cancer are discussed in [28] . A clinically validated model of tumor-immune cell interactions is considered in [4] . A new mathematical model for the explanation of the failure of cancer chemotherapy treatment is presented in [22] . A mathematical model based on di erential equations is used to describe the interactions between Ebola virus and wild-type Vero cells in vitro in [21] .
Beginning with the classical paper by Neumann et al [20] , various di erential equation models for the modeling of hepatitis virus infection have been proposed. Global dynamics of a delay di erential model of hepatitis B infection evolution are studied in [5, 27] . The transmission of hepatitis C virus (HCV) among injecting drug users is modeled using ordinary di erential equations in [11] . A mathematical multi-scale model of the within-host dynamics of HCV infection is used to study patients under treatment with direct acting antiviral medication in [3] . The authors of [2] give a review of recent HCV kinetics models.
Reluga et al [25] present the following model of hepatitis C virus infection that explicitly includes proliferation of infected and uninfected hepatocytes:
T p t " p s`r T Tˆ ´T`I Tmax˙´d T T´` ´η˘βVT`p qI; I p t " r I Iˆ ´T`I Tmax˙`` ´η˘βVT´d I I´p qI;
where p t is time; T´p t¯represents uninfected hepatocytes; I´p t¯represents infected cells and V´p t¯represents free virus population. The parameters of (1) have the following meaning: β is the rate of infection per free virus per hepatocyte; c is the immune virus clearance rate; p is the free virus production rate per infected cell; d T , d I are death rates for uninfected hepatocytes and infected cells respectively; r T , r I are parameters of the logistic proliferation of T and I respectively; logistic proliferation happens only if T ă Tmax; parameters p s and p q represent the increase rate of uninfected hepatocytes through immigration and spontaneous cure by noncytolytic process respectively; nally the e ect of antiviral treatment reduces the infection rate by a fraction η and the viral production rate by a fraction ϵ. Ranges of parameters are given in [25] . As shown in [25] , V can be solved explicitly for patients in a steady state before treatment. Furthermore, introducing dimensionless state variables and parameters transforms (1) into:
xτ " x p ´x´yq´` ´θ˘bxy`qy`s; yτ " ry p ´x´yq`` ´θ˘bxy´dy´qy,
where x, y are dimensionless state variables for uninfected hepatocytes and infected cells respectively; r, b, θ, d, q, s P R are real parameters. System (2) can be rewritten in a more general form:
where
The main objective of this paper is to study soliton-like dynamics of the system (3). Note that since (3) is not a system of nonlinear partial di erential equations (PDEs), soliton (or solitary) solutions cannot exist, due to their de nition being closely connected to concrete physical phenomena. However, as is demonstrated in the paper, solutions that exhibit analogous dynamics to those observed in solitary solutions, can be constructed for system (3) . Since the phase trajectories of these solutions are homoclinic or heteroclinic, we refer to such solutions and homoclinic/heteroclinic solutions.
In the case a " b " , system (3) has already been shown to admit homoclinic/heteroclinic solutions [19] , [15] . Solutions described in [19] have simple monotonous transitions from two steady states, while those found in [15] exhibit much more complicated transient e ects. Because of this reason, only the latter homoclinic and heteroclinic solutions to (2), (3) are considered.
Using the inverse balancing and generalized di erential operator techniques, explicit homoclinic and heteroclinic solution existence conditions are obtained in terms of the parameters of (2). These conditions, together with explicit expressions of such solutions, provide insight not only into HCV model (2) , but also other models of nonlinear evolution.
Note that the application of direct techniques to compute the homoclinic/heteroclinic trajectories of (3) is not straightforward. For example, computation of the rst integral requires the solution of the following rst-order ODE:
While the above ODE can be integrated for some parameter values, there is no general method to determine such cases. Furthermore, the generalized di erential operator technique yields not only phase trajectories of (3), but also its general solution and the conditions with respect to a , . . . , a ; b , . . . , b under which homoclinic/heteroclinic solutions exist.
Preliminaries . Power series and their extensions
In this paper, functions of the following power series form are considered:
where z, a j P C. The coe cients of power series (33) are constructed via generalized di erential operator technique, described in the following sections of the paper. We treat the convergence of series (33) as follows. If (33) converges in some ball |z| ă R; R ą , then it is possible to extend (33) to a wider complex domain (not including the singularities of (33)) via classical extension techniques. Let t P R denote a real argument of this extended function. Inserting t into the extension of (33) yields a real power series f pxq de ned for values not necessarily in the radius |t| ă R. For the purposes of this paper, we consider f pxq and its power series representation to be congruent.
. Monotonous and non-monotonous homoclinic/heteroclinic solutions
First, let us consider monotonous homoclinic and heteroclinic solutions of the following soliton-like form [23, 26] :
where η ‰ , σ, γ P R are constants; τ pxq , τ pyq depend on initial conditions u, v.
The biological interpretation of (6), (7) represents the transition from the size of population of cells before therapy to the size of population after therapy. However, this transition is monotonous; the solutions shown in Fig. 1 (a) describe the di erence between the sizes of populations before and after therapy, and the transition between the steady states.
Non-monotonous homoclinic/heteroclinic solutions read [7, 26] : 
where η ‰ , σ, γ P R are constants; τ (9) describe much more complex transition processes between the steady states. The size of the population of cells during the transient process exceeds populations both at the beginning and the end of the therapy if only the considered solutions have minimum points (the black line in Fig. 1 (b) ). Analogously, 
solutions with maximum points describe complex transitions from the population of cells before and after the treatment (the gray line in Fig. 1 (b) ).
From the biological point of view, transient processes governed by homoclinic and heteroclinic solutions highlight important phenomena. Let us consider the dynamics of uninfected cells (the black line in Fig. 1 (b) ). The population of uninfected cells after the therapy becomes lower than the population before the therapy. However, the number of uninfected cells grows during the therapy and exceeds the population of uninfected cells at the beginning of the computational experiment ( Fig. 1 (b) ).
Note that the negative values of cell population xpτq and ypτq are a consequence of the nondimensionalization of system (1).
. Solution transformation
In the following derivations, the standard independent variable transformation will be used:
Using (10), homoclinic/heteroclinic solutions (8), (9) can be written as:
where t
Using partial fractions (11), (12) can be rewritten as:
. Generalized di erential operator technique
In this section, a summary on the generalized di erential operator technique for the construction of solutions to ordinary di erential equations in presented. More detailed derivations can be found in [16] .
. . Generalized di erential operators
Let Ppc, u, vq, Qpc, u, vq be trivariate analytic functions. A generalized di erential operator Dcuv reads:
where D β :"
B Bβ
for any variable β. Standard properties of di erentiation operators hold true for (15) [14] :
where f , g denote arbitrary functions analytic in c, u, v.
. . Multiplicative operators
Using (15), the multiplicative operator can be constructed:
where t is an arbitrary real variable. Operator (19) has two important properties:
Note that (20) follows immediately from the de nition of (19) . Without loss of generality, the proof of (21) for multiplicative operator M "
Qpu, vqDv˘j is presented below. Let y :" Mu " y pt, u, vq, y :" Mv " y pt, u, vq, z :" Mf pu, vq " zpt, u, vq and w :" f pMu, Mvq " f py , y q. To prove (21) , it needs to be shown that z " w for all t, u, v.
Note that:
Thus, the function zpt, u, vq satis es the partial di erential equation:
with initial condition zp , u, vq " f pu, vq that follows from the de nition of z. Analogously, it is shown that:
with y p , u, vq " u and y p , u, vq " v. Using (24) and the de nition of w yields:
Note that w satis es the initial condition wp , u, vq " f`y p , u, vq, y p , u, vq˘" f pu, vq, thus z and w coincide, which results in the proof of (21). Construction of general solutions to ODEs requires one nal operator which is denoted as the generalized multiplicative operator:
Operator G has two properties analogous to (20) , (21):
where f is a trivariate analytic function. The proof of (28) follows from (21):
Substituting t for t´c yields (28).
. . Construction of solutions to ODEs
Let us consider the following system of ODEs:
where P, Q are analytic functions. The generalized di erential operator respective to (30) reads [13] :
Using (31), general solution to (30) is expressed as [13, 14] :
The convention D p cuv " I, where I is the identity operator, is used. Identities (32) can be proven using properties (21) and (28) derived in the previous section. Consider operators M, G de ned with respect to the generalized di erential operator (31). First, let z " zpt, p c, u, vq " Mu and w " wpt, p c, u, vq " Mv. Property (21) yields:
Analogously,
Selecting p x " zpt´c, p c, u, vq " Gu and p y " wpt´c, p c, u, vq " Gv yields the system (30). Furthermore, the de nition of operator G yields that p x t"p c " u and p y t"p c " v, thus (32) hold true.
In the following derivations, the notation
will be used, which transforms (32) into:
Furthermore, coe cients p j , q j satisfy recurrence relations:
Existence of homoclinic/heteroclinic solutions in (30)
Let ρ ‰ ρ . If (30) admits solutions (13), (14) then (13) and (36) must be equal. Expanding (13) in a power series and equating to (36) yields:
Note that p " u by (35), thus (39) yields:
Analogous derivations with respect to y and ν ‰ ν result in:
Thus (30) admits solutions (13), (14) if and only if (41), (43) hold true.
Theorem 3.1. System (30) admits homoclinic/heteroclinic solutions (13) , (14) with ρ ‰ ρ if and only if:
Proof. It will be proven that (41), (43) 
Solving the above equations for λ , λ results in (44). Equation (41) yields the following determinant equality:
Expanding the left side of (51) yields:
Solving (52) for ρ k results in:
Since ρ ‰ ρ , the discriminant ∆ ´ ∆ ∆ ‰ , which results in condition (47).
Denoting Θ :" b ∆ ´ ∆ ∆ and applying operator D p cuv to (56) results in:
Using recursion (38) it can be obtained that:
Relation (41) transforms (53)-(55) and Θ into:
Furthermore,
Inserting (62)-(69) into (57) yields (45).
Applying operator D p cuv to (44) and using (45) yields:
Inserting (41) into (70) results in (46). Su ciency. Condition (44) yields:
Applying operator D p cuv to (71) results in:
Continuing by induction yields (41).
The proof for parameters of y is analogous.
Corollary 3.1. If conditions of Theorem 3.1 hold true, then the third and higher order Hankel determinants of sequences
. . are equal to zero:
n " , , . . ..
Proof. Proof results from the derivation of Theorem 3.1 and (41), (43).

Necessary homoclinic/heteroclinic solution existence conditions in (3)
The inverse balancing technique can be used to determine necessary existence conditions of solutions (8), (9) to (3). The main principle of this technique is to insert the solution ansatz into the considered equations and obtain a system of equations linear in system parameters a k , b k , k " , . . . , . The inverse balancing technique has been successfully used to obtain necessary solution existence conditions in a variety of nonlinear ordinary and partial di erential equations [10, 15, 18] . Note that the inverse balancing technique does not possess the drawbacks associated with various solution construction (or direct ansatz) methods, which have attracted a signi cant amount of criticism [1, 8, 9, 17, 24] .
. Transformation of (3)
Using the substitution (10), system (3) is transformed to:
with initial conditions
The following notations are introduced:
Yptq :"`t´p y 
which transform solutions (11), (12) to:
.
Necessary existence conditions for (79) in (75)
Following the inverse balancing technique, solution ansatz (79) is inserted into (75). After simpli cation, (75) reads:
ηtσTy`X t Tx´X pTxq t˘" a T x Ty`a σTx Ty X`a σ X Ty`a σγXYTx`a γYT x ; (80)
Equation (78) 
Equations (85)- (88) have nontrivial solutions only if:
thus (75) (and conversely (3)) only admits homoclinic/heteroclinic solutions with equal denominators. Let t :" t pxq " t pyq and t :" t pxq " t pyq . Equation (89) transforms (79) into:
where Tptq :" pt´t q pt´t q.
. Necessary existence conditions for (90) in (75)
If (89) holds true, (80), (81) read:
Note that
and
Taking t " t , t in (91) and using (93), (94) yields:
ηt pt ´t q " σX pt q a `γY pt q a ; (95) ηt pt ´t q " σX pt q a `γY pt q a .
Analogous computations with respect to (92) result in:
Solution of (95)- (98) with respect to a , a , b , b reads:
Similarly, taking t " p x , p x in (91) and t " p y , p y in (92) yields the following solutions for a , a , b , b :
Finally, taking t " in (91), (92) yields a , b :
Note that there are 10 parameters in (75) and (91), (92) yields a non-degenerate system of 10 linear balancing equations, thus no constraints on the parameters of solution (90) needs to be imposed. However, as shown by (99) 
Parameter η does not depend on u, v only if:
which leads to the following su cient existence condition for homoclinic/heteroclinic solutions to (3):
If (123) 
. Necessary and su cient existence conditions for homoclinic/heteroclinic solutions to (3)
Theorem 3.1, Lemma 4.1 and condition (123) together with computer algebra computations result in the following theorem.
Theorem 5.1. System (3) admits homoclinic/heteroclinic solutions (8), (9) if and only if conditions (107), (108) and (123) hold true.
where ρk " ρk pu, vq.
Relations between parameters of (13), (14) and (8), (9) read:
Parameters σ, γ read:
Note that (117) yields two values for η, however, it is su cient to consider only the positive or negative root of (117) to obtain the general solution to (3) when Theorem 5.1 holds true, because the sign of η can be interchanged:
As demonstrated in [15] , the value x x τ τ does not depend on initial conditions, which proves that changing the sign of η does not yield new solutions.
Homoclinic/heteroclinic solutions to hepatitis C model (2) . Existence conditions
Comparing (2) to (3) it can be observed that:
To preserve biological signi cance of system (2), the parameters ( 
Both equations are satis ed if parameter r reads:
Let (137) hold true. Denote Ω :" b` ´θ˘` ´d´q " r´d´q. Inserting (134), (135) into condition (123) yields:
Equations (137) and (138) Computer algebra computations prove that when Corollary (6.1) holds true, parameters y " y " .
. Equilibria
Let (137) and (138) hold true. The equilibria of (2) read:
Equilibrium point (141), (142) is a stable node as τ Ñ`8:
Equilibrium point (139) is an unstable node as τ Ñ´8:
The remaining equilibrium point (140) is a saddle point.
. Computational experiment
Let us consider the following system:
yτ " y p ´x´yq´ xy´ y; y
The above system corresponds to (2) with the following parameters:
Note that parameters (147) satisfy the guidelines given in [25] for biologically signi cant systems. Furthermore, conditions of Corollary 6.1 are satis ed, thus homoclinic/heteroclinic solutions to (145), (146) do exist. Equation (117) yields:
As noted previously, it is su cient to consider one value of η to obtain the general solution to (145), (146). In subsequent computations the value η " is used. Theorem 3.1 yields the following parameters of homoclinic/heteroclinic solutions: 
. Labels (a), (b), (c), (d) correspond to respectively labeled phase plane trajectories in Fig. 3 .
Derivations given in Subsection 5.2 result in: Solutions with parameters (153)-(155) are pictured in Fig. 2 . Note that there are three types of solutionsnon-singular solutions (a), (b); solutions with one singularity (c) and solutions with two singularities (d).
The phase plane of (145), (146) can be seen in Fig. 3 . Note that labels (a), (b), (c), (d) on the phase plane correspond to respectively labeled solutions pictured in Fig. 2 . System (145), (146) has the following equilibriá , ¯-stable node;´´ , ¯-unstable node;´ , ¯-saddle point. It has been proven in [15] that homoclinic/heteroclinic solutions of the form (8), (9) correspond to phase plane trajectories that satisfy the general conic section equation:
Ax `Bxy`Cy `Ex`Fy`G " ; A, B, C, E, F, G P R.
Solution Fig. 3 (a) corresponds to an elliptic trajectory, while the remaining (b), (c), (d) have hyperbolic trajectories. Furthermore, there is a single solution that satis es the parabola equation:
Curve (157) is a separatrix that separates solutions with and without singularities in the phase plane (see dashed gray parabola in Fig. 3 ).
Stable and unstable manifolds of the saddle point are obtained by setting the numerator and denominator of τ , to zero [15] . This yields that the stable manifold of the saddle point is the x-axis, while the unstable manifold lies on the straight line y "´ x` . Manifolds of the saddle point correspond to dashed gray lines in Fig. 3 .
Concluding remarks
Homoclinic and heteroclinic solutions to hepatitis C evolution model (2) have been constructed in this paper. Inverse balancing and generalized di erential operator techniques have enabled the derivation of explicit necessary and su cient homoclinic and heteroclinic solution existence conditions with respect to the parameters of system (2). Furthermore, it has been shown that these existence conditions are satis ed when (2) described a biologically signi cant system of HCV evolution.
It has been demonstrated that transient processes of the derived solutions to (2) reveal important phenomena for understanding hepatitis C virus infection dynamics. Even though antiviral therapy reduces the number of infected cells (comparing the beginning to the end of treatment), due to the transient processes during the therapy, population size of infected cells is higher than before or after therapy -if only the considered solutions are heteroclinic with maxima. Analogous biological interpretations can be made for heteroclinic solutions with minima. The population of healthy cells is lower than before or after treatment during antiviral therapy -if the number of uninfected hepatocytes is described by a heteroclinic solution possessing minima.
The main mathematical advancements of this paper can be characterized by new applications of inverse balancing technique and the development of generalized di erential operator method for the solution of coupled di erential equations with multiplicative and di usive terms. As noted in Section 4, direct balancing techniques may yield wrong solutions; inverse balancing of such a complex system of nonlinear di erential equations poses a number of technical problems. On the other hand, derivation of closed-form homoclinic/heteroclinic solutions and explicit conditions of their existence poses serious mathematical challenges. One of the main contributions of this paper are the necessary and su cient conditions for the existence of these solutions in the hepatitis C evolution model.
Comparing the results of this paper with [15] it can be concluded that system (3) (and, by extension (2)) is structurally stable in the topological sense -when a , b tend to zero, the phase plane continuously converges to the phase plane described in [15] . Moreover, structural stability can also be observed in homoclinic/heteroclinic solution existence condition (123) -in the case a , b Ñ , such solutions also exist and the condition (123) is maintained. Since such e ects are observed in systems with biological signi cance, they provide valuable insight not only into (2) but also other nonlinear evolution models.
